Pterostilbene attenuates lung ischemia-reperfusion injury: integrative insights from network pharmacology, molecular dynamics, and experimental validation
Frontiers in Pharmacology · 01.04.2026 · 17
DOI: 10.3389/fphar.2026.1747977 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 01.04.2026. Verfasst von Haotian Bai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Lung ischemia-reperfusion injury (LIRI) is a principal cause of primary graft dysfunction (PGD) following lung transplantation, severely compromising recipient survival. However, effective therapies remain unavailable due to its complex pathophysiology. Pterostilbene (PTE) is a natural stilbene compound known for its well-documented anti-inflammatory, antioxidant, and antitumor properties. However, its effects and underlying mechanisms in LIRI remain unclear.
Methods
Potential targets of PTE and LIRI were retrieved from multiple public databases, followed by network analysis and functional enrichment to identify core targets and pathways. Molecular docking and dynamics simulations were conducted to assess the binding affinity and stability between PTE and its core targets. Finally, a rat left hilar clamping model and an OGD/R model in BEAS-2B cells were employed to experimentally validate the protective effects and molecular mechanisms of PTE.
Results
A total of 104 intersecting targets were identified with ten core genes such as PIK3CB and MAPK8 highlighted. Gene Ontology and KEGG analyses revealed significant enrichment in apoptosis- and inflammation-related pathways, particularly PI3K/AKT and MAPK signaling. Docking and simulation results demonstrated stable binding of Pterostilbene to core targets (binding energy ≤−5.6 kcal/mol). In vivo , PTE alleviated IR-induced lung injury, reduced pulmonary edema, apoptosis, and pro-inflammatory cytokine release. In vitro , PTE enhanced cell viability, decreased the levels of pro-inflammatory cytokines, inhibited Caspase-3 activation and Bax expression, and increased Bcl-2 levels. Mechanistically, PTE promoted PI3K/AKT activation while suppressing JNK/c-Jun phosphorylation both in vivo and in vitro . Notably, LY294002 (a PI3K inhibitor) and Anisomycin (a JNK activator) partially reversed the anti-apoptotic and anti-inflammatory effects of PTE, respectively.
Conclusion
This study provides the first integrated evidence combining network pharmacology and experimental validation that PTE protects against LIRI by modulating the PI3K/AKT and JNK/c-Jun signaling pathways, offering novel pharmacological insights into its translational potential in LIRI.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
- Key Laboratory of Enhanced Recovery After Surgery of Integrated Chinese and Western Medicine, Administration of Traditional Chinese Medicine of Shaanxi Province, The First Affiliated Hospital of Xi'an Jiaotong Universit…
- Department of Nuclear Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Zitieren
APA
Bai, H., Zhao, H., Feng, J., Wang, H., Li, Y., Chen, Z., He, B., Wang, C., Gao, R., Zhao, R., Gao, S., & Zhang, G. (2026). Pterostilbene attenuates lung ischemia-reperfusion injury: integrative insights from network pharmacology, molecular dynamics, and experimental validation. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1747977
Vancouver
Bai H, Zhao H, Feng J, Wang H, Li Y, Chen Z, et al. Pterostilbene attenuates lung ischemia-reperfusion injury: integrative insights from network pharmacology, molecular dynamics, and experimental validation. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1747977
BibTeX
@article{Bai2026,
author = {Bai, Haotian and Zhao, Heng and Feng, Jinteng and Wang, Hongyi and Li, Yixing and Chen, Zhe and He, Bin and Wang, Chi and Gao, Rui and Zhao, Rui and Gao, Shan and Zhang, Guangjian},
title = {Pterostilbene attenuates lung ischemia-reperfusion injury: integrative insights from network pharmacology, molecular dynamics, and experimental validation},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1747977}
}
EUVIMED